Related by context. Frequent words. (Click for all words.) 70 ICOS Corporation 68 Bayhill Therapeutics 67 Files Shelf Registration Statement 65 CoMentis 65 AVEO Pharmaceuticals 65 Cerus Corporation 65 Merrimack Pharmaceuticals 65 Connetics Corporation 65 Rhone Poulenc Rorer 64 Andrx Corporation 64 OncoGenex Technologies 63 Vicuron Pharmaceuticals 63 Initiates Phase II 63 ALZA Corporation 63 Metabasis Therapeutics Inc. 63 CEO Exercises Options 62 EntreMed Inc. 62 Lexicon Genetics 62 Altus Pharmaceuticals 62 Maxim Pharmaceuticals 62 Elixir Pharmaceuticals 62 Trubion Pharmaceuticals 62 Taligen 62 Enzon Pharmaceuticals 62 Idera Pharmaceuticals 61 Inc Therapeutic Competitors 61 Genaera Corporation 61 Receives Orphan Drug Designation 61 Emisphere Technologies 61 Adnexus Therapeutics 61 Q2 Loss Widens 61 Q2 Loss Narrows 61 Ore Pharmaceuticals 61 Actelion Ltd 61 Q3 Loss Narrows 61 Announces Stockholder Approval 61 Q1 Loss Narrows 61 OPKO Health 60 Diatos 60 Files Annual Report 60 Transcept Pharmaceuticals 60 Diversa Corporation 60 Exploit collaboration 60 Stockholders Approve Merger 60 Reliant Pharmaceuticals 60 Progenics Pharmaceuticals 60 Abraxis Bioscience 60 Q4 Loss Narrows 60 Opko Health 60 Tranzyme Pharma 60 Pharmion Corporation 60 CureDM 60 FluoroPharma 60 QuatRx 60 Cyclacel Pharmaceuticals 60 Flamel Technologies 60 Corautus Genetics Inc. 60 Adeona Pharmaceuticals Inc. 60 Advanced Magnetics 60 ACLARA 60 OncoMed Pharmaceuticals 60 Syntonix 60 Aerovance 60 Completes Tender Offer 60 Serologicals Corporation 60 Vaccinex 60 VIA Pharmaceuticals 60 Explore Strategic Alternatives 60 Cilag GmbH International 59 Symyx Technologies 59 Q2 Profit Surges 59 Nastech Pharmaceutical Company 59 Sunesis Pharmaceuticals 59 Alnara 59 Chemokine Therapeutics 59 Prestwick Pharmaceuticals 59 Bearish Pressure Building 59 MedImmune Ventures 59 ESP Pharma 59 Inc. Nasdaq IMGN 59 Portola Pharmaceuticals 59 Nasdaq BIIB 59 quotes/comstock/# * 59 EPIX Pharmaceuticals 59 Idenix Pharmaceuticals 59 NovaBay Pharmaceuticals 59 Anthera Pharmaceuticals 59 NASDAQ CRXL 59 CFO Resigns 59 Presents Positive 59 Urigen Pharmaceuticals Inc. 59 Nasdaq VRTX 59 CoTherix Inc. 59 Holds Annual Meeting 59 Discusses Q3 59 Director Exercises Options 59 Lexicon Pharmaceuticals 59 Repligen Corporation 59 Omni Bio 59 NASDAQ LGND 59 Regains Compliance With